Plasmatic Signature of Disease by Differential Scanning Calorimetry (DSC) by Tsvetkov, Philipp, & Devred, François
HAL Id: hal-02088538
https://hal-amu.archives-ouvertes.fr/hal-02088538
Submitted on 3 Apr 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Plasmatic Signature of Disease by Differential Scanning
Calorimetry (DSC)
Philipp Tsvetkov, François Devred
To cite this version:
Philipp Tsvetkov, François Devred. Plasmatic Signature of Disease by Differential Scanning Calorime-
try (DSC). Microcalorimetry of Biological Molecules: Methods and Protocols, Springer, pp.45-57,
2019, 978-1-4939-9179-2. ￿10.1007/978-1-4939-9179-2_4￿. ￿hal-02088538￿
Plasmatic Signature of Disease by Differential Scanning
Calorimetry (DSC)
Philipp O. Tsvetkov and François Devred
Abstract
Differential scanning calorimetry (DSC) has been used for several decades to characterize thermal stability
of macromolecules such as proteins and DNA. It allows to determine the denaturation temperature and
enthalpy of individual domains of proteins, thus giving new insights into their domain organization and
ligand interaction. Over the past decade, it has been shown that this technique can also be used to study
biofluids such as plasma or cerebrospinal fluid to obtain denaturation profiles. An increasing number of
studies demonstrated that such profiles obtained from patients were significantly different from profiles
obtained using biofluids of healthy individuals. This opens interesting perspectives for new diagnostics and
monitoring tools for a large number of diseases. Nevertheless, the extensive studies of plasma samples from
patients with different pathologies as well as the development of standardized methods of data analysis are
necessary to reach the promising diagnostic potential of this methodology. Using plasma samples from
healthy individuals and glioblastoma patients, we outline the steps necessary to obtain a plasmatic calori-
metric profile with VP-DSC instrument and describe a cluster analysis of obtained data.
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1 Introduction
Differential scanning calorimetry (DSC) is a powerful biophysical
method which in its conventional use characterizes the stability of a
purified protein or other biomolecule directly in solution. It mea-
sures the heat exchange associated with the molecule’s thermal
denaturation when heated at a constant rate [1, 2]. It has several
important applications including quality control of pharmaceutical
preparations, nanoparticle stability, tertiary structure characteriza-
tion, and interaction studies [3]. For purified single-domain pro-
teins, the profile of denaturation obtained by DSC is usually
characterized by a single peak. The maximum of this peak corre-
sponds to the melting temperature (Tm) and the area under the
curve to the enthalpy of denaturation (ΔH). These two parameters
are characteristic for each protein at given conditions. Any
modification in the protein structure such as mutations, posttrans-
lational modifications, or interaction with any kind of ligand could
impact protein stability and thus be detected using DSC.
More recently, a less conventional use of DSC has been pro-
posed. It consists in applying DSC directly to biofluids, such as
serum, plasma, or cerebrospinal fluid, rather than to purified bio-
molecules. The denaturation profiles of biofluids obtained by DSC
correspond to the superposition of denaturation calorimetric pro-
files of all components in the biofluid sample.
The modifications in blood composition of patients suffering
from a disease can lead to significant and reproducible changes in
calorimetric profile of plasma corresponding to specific signature of
the disease. Just like for purified proteins, the change in profile can
be due to any of the modifications mentioned above (mutation,
ligand, posttranslational modification) or the change in concentra-
tion of circulating proteins.
Over the past 5 years, an increasing number of publications
have shown that such impact exists in many diseases including
several types of cancer [4–10].
In this chapter we describe the straightforward way to obtain
plasmatic thermograms by DSC taking as an illustration the profiles
of healthy individuals and patients suffering from glioblastoma. We
also present how these profiles can be analyzed using cluster
analysis.
2 Materials
Prepare all solutions using ultrapure water and analytical grade
reagents. All consumables that are in contact with plasma should
be recycled properly, and all instruments that are in contact with
plasma should be sterilized.
2.1 Plasma Sample
Preparation
1. Lavender cap vacutainers are used to collect blood and prepare
plasma. They are commercially treated with EDTA to prevent
coagulation of the blood (see Note 1).
2. Heraeus Multifuge X3R centrifuge equipped with TX 1000
swinging buckets.
2.2 Sample
Preparation
1. To prepare 100 mL of dilution buffer, add 0.33 g of trisodium
citrate to final volume of 100 mL of phosphate-buffered saline
(PBS).
2. Polypropylene cryovials and Eppendorf tubes.
2.3 Obtention
of Plasma DSC Profiles
1. DSC thermograms are collected using a differential scanning
VP-DSC microcalorimeter (MicroCal, Malvern Panalytical) or
any analog instrument.
2. Associated instruments such as ThermoVac (MicroCal) and cell
cleaning apparatus are used to facilitate degassing samples and
cleaning of the cells.
3. Origin 7 software (OriginLab Corporation, Northampton,
MA) is used to treat raw data and obtain thermograms.
4. Hamilton syringe to fill the calorimetric cells.
2.4 Cluster Analysis 1. Wolfram Mathematica 11.0 software.
2. Microsoft Excel software.
3 Methods
Carry out all procedures at room temperature unless otherwise
specified.
3.1 Plasma
Preparation
Plasma is produced when whole blood is centrifuged in tubes that
are treated with an anticoagulant. The blood does not clot in the
plasma tube. The cells are removed by centrifugation. All plasma
sample manipulations should be carried out with appropriate pre-
cautions using gloves and throwing all consumables in dedicated
yellow trash boxes.
1. Collect whole blood into EDTA-treated vacutainer (lavender
cap).
2. Equilibrate the tubes in the TX 1000 rotor of the X3R
centrifuge.
3. Centrifuge 1000  g at 20–25 C for 20 min (see Note 2).
4. Following centrifugation, it is important to immediately trans-
fer the liquid component (plasma) into a clean polypropylene
tube by aspiration (see Note 3).
5. The samples should be maintained at 2–8 C while handling. If
the plasma is not analyzed immediately, the plasma should be
separated into 0.5 mL aliquots and stored at 20 C or lower.
6. Unprocessed plasma samples are stored at80 C (seeNote 4).
3.2 Sample
Preparation
1. Before DSC analysis, thaw the samples rapidly at 37 C, and
then pipet 40 μL of plasma into a final volume of 1 mL of
dilution buffer.
2. Diluted samples can be stored at 20 C when not in use.
3.3 Obtention
of Plasma DSC Profiles
3.3.1 Instrument Settings
Configure DSC instrument using control software and the follow-
ing settings:
1. Number or scans: 2.
2. Post-cycle thermostat: 10.
3. Cell concentration (mM): 1 (see Note 5).
4. Starting temperature (C): 10.
5. Final temperature (C): 120.
6. Scan rate (/h.): 60.
7. Prescan thermostat (min): 15.
8. Postscan thermostat (min): 0.
9. Filtering period: 2.
10. Feedback mode/gain: Mid.
3.3.2 Cell Filling
and Running Experiment
All manipulations with calorimetric cell should be performed with
extra care to avoid damaging cell with filling syringe and contami-
nation with biofluids (always use gloves when working with plasma
samples).
1. Fill the Hamilton syringe with at least 580 μL of buffer at room
temperature (see Note 6).
2. To degas the sample, block the tip of the syringe, and slowly
pull the piston up to twice the volume of the sample. Release
slowly the piston to initial position. Repeat three times.
3. Insert the filling funnel into expansion on the top of the
calorimetric cell.
4. Introduce the filling syringe into calorimetric cell through
filling funnel.
5. To inject in the calorimetric cell, push the syringe piston slowly
until half of solution volume is injected, and then inject the rest
by doing several small but rapid injections. This should be done
while moving the syringe toward the top of the cell (see Note
7).
6. Proceed with the injection up to the point when the sample
overflowing the calorimetric cell (see Note 8).
7. Remove this overflowing liquid with the syringe.
8. Close the instrument by rotating first the metal and then plastic
part of the cap (see Note 9).
9. Select “DSC instruments” in the main window tab selections.
10. Verify instrument settings (see above).
11. Press start in the main window buttons (see Note 10).
3.3.3 Cleaning Between each plasma sample analyzed, the cell must be cleaned
extensively to prevent attachment of aggregates on the cell walls
(see Note 11). For this purpose, the ThermoVac in conjunction
with its cell cleaning device can be used to circulate cleaning and
rinsing solutions through the calorimetric cells.
1. Clean the cell as follows:
(a) Empty the cell with a dedicated syringe.
(b) Fill it with Decon 10–20% by syringe; push-pull piston few
times.
(c) Remove Decon.
(d) Wash cell with 50–100 mL water using the ThermoVac
(see Note 12).
(e) Rinse three times with buffer (see Note 13).
2. Extra cleaning:
(a) Fill the cell with Decon detergent 20% (see Note 14).
(b) Select “Thermostat/Calib.” in the main window tab
selections to set the jacket temperature at 60 C.
(c) Leave for 1 h and then change the jacket temperature to
25 C.
(d) Leave overnight.
(e) Next morning empty the calorimetric cell and use the
normal cleaning procedure.
(f) If this procedure is still not enough, Decon 20% can be
replaced with 5% NaOH (see Note 15).
3. Clean filling funnel by rinsing it with excess of water and
methanol, and then sterilize it.
4. Clean filling syringe by rinsing it with excess of water and
methanol, and then sterilize it.
3.4 Raw Data
Processing
1. Thermograms are treated using software Origin 7.
2. Select “read data,” select the two files corresponding to the two
scans, and click “Add files” and then “Ok” (Fig. 1a).
3. In the top menu, select “Math” and then “simple math.”
4. In the pop-up window, select the first scan name in the field
“Y1” and the second scan name in the field “Y2” by scrolling
“Available data” list and pressing corresponding button with
arrow “)”. Then put “” (minus) sign in “Operator” field
and press “Ok” (Fig. 1b, black solid curve).
5. At this point, the resulting scan replaced the first one so you can
remove the second scan.
6. Peak> Start Baseline Session; red segments will appear on both
sides of the thermogram (Fig. 1b, red segments).
7. Adjust > move segments by cursors; match the red segments
with the segment of the experimental curve you want to use for
baseline usually 10–40 C and 84–100 C (see Note 16) and
press “enter.”
8. Select “Baseline” with “cubic connect” and press OK (Fig. 1b,
black dashed curve).
9. Confirm that you want to subtract baseline (Fig. 1c, black solid
curve).
10. From the Tool menu under the graphic, use the “data selector”
to choose the segment of the curve that will not be analyzed
(0–40 C and 100–120 C), and press “enter” to validate
selection and “suppr” to delete it (Fig. 1c).
11. In the side menu, select “Normalize concentration,” put “1,”
and click “Ok” (Fig. 1d) (see Note 17).
12. In the top menu, click “Window” to select the processed curve;
that will open you the table of values.
13. Select File Export To Ascii and save your data as a .DAT file.
Fig. 1 Stages of raw DSC data processing. (a) First (solid curve) and second (dashed curve) DSC scans. (b)
Difference between first and second scan (solid black curve), segments for baseline creation (red lines and
squares), and created baseline (dashed curve). (c) Experimental curve with subtracted baseline and fragments
of the curve marked with double-arrowed cursors a-b and c-d that should be removed. (d) Final excess heat
capacity curve after concentration normalization
3.5 Cluster Analysis The general information about cluster analysis can be found in the
following publications [11, 12].
1. Average thermograms obtained from the patients and healthy
individuals and patients, and find the difference between them.
For that purpose:
(a) Create folder and copy to it all DSC “*.dat” files obtained
from healthy individuals (Fig. 2a).
(b) Create folder and copy to it all DSC “*.dat” files obtained
from patients (Fig. 2b).
(c) Create new Notebook in Mathematica software; copy in it
the code from Annex 1.
(d) Replace ##Dir1## and ##Dir2## in the code (lines
21 and 26) by paths to newly created folders (see Note
18), and replace ##FigureDir## (line 71) by path to
folder where you want to save the figure file.
(e) Modify if necessary the parameters in the code (see Note
19).
(f) Press “Shift+Enter” to run the code (see Note 20). In
directory ##FigureDir## new ready-to-publish image file
“FigureDSC.png” with resulting averaged curves and
their difference will be created (Fig. 3).
2. From difference curve drawn at the bottom panel of obtained
figure, determine at what temperature the thermograms of
patients are most different from the ones of healthy individuals
by defining the positions of the extremums of difference curve
(see Note 21).
3. Create Excel file and fill its table with the values of each experi-
mental curve at temperatures chosen at previous step.
4. Add to table the columns with other characteristics of the
experimental curves, such as positions and values of the maxima
of each curve, surface under the curves, or any other
Fig. 2 Calorimetric profiles of plasma obtained from 10 healthy individuals (a) and 17 GB patients (b)
parameters of the curves you believe could differ profiles of
healthy individuals and patients.
5. Save resulting table in “DSC_Data.xlsx” file.
6. Perform cluster analysis of these data for that purpose:
(a) Create new Notebook in Mathematica software; copy in it
the code from Annex 2.
(b) Replace in the code ##Dir_of_xls_file## at line 1 by the
path to directory where you saved “DSC_Data.xlsx” file.
(c) Replace in the code ##FigureDir## at line 31 by the path
to directory where you want to save the resulting figure
file with clusters (see Note 18).
(d) Modify if necessary the number of clusters set by default
equal to 4 in line 5 (parameter numberOfClusters) and
clustering method in line 8 (parameter Method! “Opti-
mize”). For options of clustering, see online Wolfram
Language documentation [13]. Modify if necessary any
other parameters in the code (see Note 19).
Fig. 3 The example image generated by code from Annex 1 in Wolfram Mathematica software. In this example
(a) represents the average of plasma denaturation profiles from 10 healthy individuals (blue solid curve) and
17 GB patients (red dashed curve). Filled area corresponds to standard deviation. (b) Difference between
averages of plasma denaturation profiles from healthy individuals and GB patients
(e) Press “Shift+Enter” to run the code (see Note 20). In
directory ##FigureDir## new Clusters.png file with
results of cluster analysis will be created (Fig. 4).
4 Notes
1. Citrate-treated (light blue caps) could probably be used too,
but heparinized tubes (green tops) can be contaminated with
endotoxin, which can stimulate white blood cells to release
cytokines.
2. Samples should not be put on ice; otherwise they will
hemolyse.
3. If supernatant appears too pink, it is probably a sign of hemo-
lysis which will invalidate the obtained profile.
4. No other specific purification step is added in order to avoid
perturbing the interactome or alter the chemical state of plasma
proteins.
Fig. 4 The example image generated by code form Annex 2 by Wolfram
Mathematica software. In this example, all curves were divided into four distinct
clusters, wherein open circles correspond to healthy individuals and filled
shapes to glioblastoma patients
5. Value of 1 is put arbitrarily because one cannot perform an
experiment if concentration is not specified.
6. Even though the cell volume is only 400 μL, 580 μL is neces-
sary to guarantee the absence of bubbles in the cell.
7. Short rapid injections will help remove eventual bubbles
attached to the cell walls.
8. This procedure also decreases the chances of having bubbles
trapped in the cell.
9. Verify that the pressure increases upon rotation of the plastic
cap and reaches 30 psi when the rotation is finished. This will
prevent sample boiling at high temperatures.
10. After the first run is completed, the instrument will cool down
the sample and launch the second run automatically.
11. If the cleaning is not done properly, the signal will become
more and noisier after each experiment.
12. See manufacturer protocol for ThermoVac use.
13. At this point, you can run a buffer-buffer experiment; if the
signal is noisy, you can then use the extra cleaning procedure.
14. When using detergents or corrosive solution, the pressure
transducer must be closed with its dedicated white plug.
15. For other stronger cleaning procedure, see VP-DSC manufac-
turer manual.
16. Since all samples aggregate starting from 100 C, the segment
on the right should stop before.
17. Global protein concentration is not normalized so that the
profiles obtained reflect the possible differences in protein
content of plasma.
18. You can do so by holding “Alt” key and dragging and dropping
the directory in the desired place in the Notebook.
19. For quick guide to Mathematica code, see ref. [14].
20. The execution of the code could take several minutes.
21. In our case, there are two extremums; it could be also more.
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Annex 1
1. drawCurves[data0_, colr0_, style0_] :=
2. Module[
3. {data = data0, colr = colr0, style = style0},
4. filetredLists = Transpose /@ ({#1, WienerFilter[#2, 1, .1]} & @@@ Transpose /@
data);
5. ip = Interpolation /@ filetredLists;
6. average[x_] := Mean@Through[ip[x]];
7. sd[x_] := StandardDeviation@Through[ip[x]];
8. maximal[x_] := Max@Through[ip[x]];
9. plt1 = Plot[average[x], {x, 40, 100}, PlotStyle -> {Thick, colr, style}];
10. pltsd = Plot[sd[x], {x, 40, 100}, PlotStyle -> {Thick, colr}];
11. plt2 = Plot[{average[x] - sd[x], average[x]}, {x, 40, 100},
12. Filling -> {1 -> {2}}, PlotStyle -> {{Thin, colr}, {Thin, colr}},
13. FillingStyle -> {colr, Opacity[0.2]}];
14. plt3 = Plot[{average[x], average[x] + sd[x]}, {x, 40, 100}, Filling -&gt; {1 -
&gt; {2}},
15. PlotStyle -> {{Thin, colr}, {Thin, colr}},
16. FillingStyle -> {colr, Opacity[0.2]}];
17. Show[plt1, plt2, plt3, FrameStyle -> Thickness[0.0015]]
18. ];
19.
20.
21. files1 = FileNames["*.DAT", "##Dir1##"];
22. data1 = Drop[Import[#], 40] & /@ files1;
23. cv1 = drawCurves[data1, RGBColor[0.91, 0.34, 0.247], Dashed];
24.
25.
26. files2 = FileNames["*.DAT", "##Dir2##"];
27. data2 = Drop[Import[#], 40] & /@ files2;
28. cv2 = drawCurves[data2, RGBColor[0.29, 0.573, 0.86], Solid];
29.
30.
31. getDataAv[data0_] := Module[
32. {data = data0},
33. filetredLists = Transpose /@ ({#1, WienerFilter[#2, 1, .1]} & @@@ Transpose /@ data);
34. ip = Interpolation /@ filetredLists;
35. average[x_] := Mean@Through[ip[x]];
36. Return[average[x]]
37. ];
38.
39. aa[x_] := getDataAv[data2] - getDataAv[data1];
40. difPlot =
41. Plot[aa[x], {x, 40, 100}, PlotStyle -> {Thick, Black},
42. PlotRange -> {{40, 100}, {-0.00005, 0.0005}},
43. FrameStyle -> Thickness[0.0015]];
44.
45. dscCurves =
46. Column[
47. {Show[
cv1, cv2, Frame -> True, ImageSize -> 900,
BaseStyle -> {FontFamily -> "Areal", FontSize -> 21},
FrameLabel -> {{Style["\[Laplacian]Cp", FontSize -> 32], None},
{None, Style["Temperature, \[Degree]C", FontSize -> 32]}},
FrameTicks -> {{{{-0.0002, -0.2}, 0, {0.0002, 0.2}, {0.0004, 0.4},
{0.0006, 0.6}}, None},{None, {50, 60, 70, 80, 90}}},
ImagePadding -> {{90, 10}, {0, 70}},
PlotRange -> {{40, 100}, {-0.0004, 0.0008}},
Epilog -> Style[Text["A", Scaled[{.1, .9}]], 36]
],
Show[
difPlot, Frame -> True, ImageSize -> 900,
BaseStyle -> {FontFamily -> "Areal", FontSize -> 21},
FrameLabel -> {{Style["\[Laplacian]\[Laplacian]Cp", FontSize -> 32], None},
{Style["Temperature, \[Degree]C", FontSize -> 32], None}},
FrameTicks -> {{{0, {0.0002, 0.2}, {0.0004, 0.4}, {0.0006, 0.6}}, None},
{{50, 60, 70, 80, 90}, {50, 60, 70, 80, 90}}},
AspectRatio -> 0.2,
ImagePadding -> {{90, 10}, {90, 0}},
Epilog -> Style[Text["B", Scaled[{.1, .6}]], 36]
]},
69. Spacings -> 0
70. ]
71. Export["##FigureDir##/FigureDSC.png", %, ImageResolution -> 300]
Annex 2
1. data = Import["##Dir_of_xls_file##/DSC_Data.xlsx"][[1]];
2. fdata = data // Standardize;
3. paramsN = Length[fdata[[1]]] - 5;
4.
5. numberOfClusters = 4;
6.
7. builtinscores = PrincipalComponents[fdata, Method -> "Covariance"];
8. clasters = FindClusters[builtinscores, numberOfClusters, Method -> "Optimize"];
9.
10. clasters =
11. Show[
12. clustersPlot = ListPlot[
13. clasters[[All, All, 1 ;; 2]], PlotRange -> All, ImageSize -> 730,
14.
15. PlotMarkers -> {{Style[\[FilledRightTriangle], Black], 25},
16. {Style[\[FilledSquare], Black], 25},
17. {Style[\[FilledDiamond], Black], 25},
18. {Style["\[EmptyCircle]", Black], 25}},
19. AspectRatio -> 1, Frame -> True, Axes -> False,
20. PlotStyle -> {Black, Black, Black},
21. Epilog -> Style[Text["C", Scaled[{.9, .92}]], 36]
22. ],
23.
24. FrameStyle -> Thickness[0.0025],
25. BaseStyle -> {FontFamily -> "Areal", FontSize -> 21},
26. FrameLabel -> {{Style["Component 2", FontSize -> 32], None},
27. {None, Style["Component 1", FontSize -> 32]}},
28. FrameTicks -> {{{-4, -3, -2, -1, 0, 1, 2}, None},{None, {-3, -2, -1, 0, 1, 2, 3}}}
29. ]
30.
31. Export["##FigureDir##/Clusters.png", %, ImageResolution -> 300]
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